Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Enzo Biochem Inc ENZ

Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.

NYSE:ENZ - Post by User

Bullboard Posts
Next >>
User Avatar Image
  • edwardebreen15X
Post by edwardebreen15on Aug 23, 2022 1:11am
Post# 34913250

Nucleic Acid Labelling Market Analysis & Forecast 2021-26

Nucleic Acid Labelling Market Analysis & Forecast 2021-26

According to IMARC Group’s latest report, titled “Nucleic Acid Labelling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” the global market grew at a CAGR of around 6% during 2015-2020. Nucleic acids refer to naturally occurring chemical compounds that act as major information-carrying molecules in cells. There are two types of nucleic acids, namely, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). These molecules are usually labeled with tags to facilitate identification and purification processes. Nucleic acid labeling utilizes various enzymatic and chemical methods, such as the modification of radioactive phosphates and fluorophores with biotin and digoxigenin. These processes are applied in biotechnology and life sciences to generate information on gene integrity, diagnose specific sequences, and discover protein-nucleic acid interactions.


Request for a PDF sample of this report:


The global nucleic acid labeling market is majorly being driven by the rising prevalence of genetic disorders. These techniques are being increasingly utilized across the healthcare sector for disease diagnostic and management and prenatal testing. Nucleic acid labeling helps offer tailor-made therapies to patients, which is facilitating the availability of personalized medicines. Additionally, rapid advancements in nanotechnology, such as the introduction of connected devices and artificial intelligence (AI), are creating a positive outlook for the market. Furthermore, increasing research and development (R&D) activities in genomic research is supporting the market growth. Looking forward, IMARC Group expects the nucleic acid labeling market to exhibit moderate growth during 2021-2026.


Checkout Now:


As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.


Competitive Landscape with Key Players:

  • Agilent Technologies Inc.
  • Cytiva (Danaher Corporation)
  • Enzo Biochem Inc.
  • Hoffmann LA-Roche AG (Roche Holding AG)
  • Merck KGaA
  • New England Biolabs (UK) Ltd.
  • PerkinElmer Inc.
  • Promega Corporation
  • Thermo Fisher Scientific Inc.Vector Laboratories.

Market Segmentation:


Breakup by Product:

  • Kits
  • Reagents
  • Instruments

Breakup by Labeling Type:

  • Radioisotope/Radioactive Labels
  • Non-Radioactive Labels

Breakup by Method:

  • Enzyme-based
    • PCR
    • 5’ End Labeling
    • 3’ End Labeling
    • Others
  • Chemical-based
    • Conjugation
    • Photoreaction

Breakup by Application:

  • Oligonucleotide Labeling
  • In-Situ Hybridization
  • Southern and Northern Blotting
  • Cellular Localization
  • Others

Breakup by Sector:

  • Diagnostics
  • Therapeutics
  • Research

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures


Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.


Key highlights of the report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.


Related Reports by IMARC Group:

Europe Generic Drug Market:

India Minimally Invasive Surgery Market:

United States Minimally Invasive Surgery Market:

GCC Minimally Invasive Surgery Market:

Mass Spectrometry Market:


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.


IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:


30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming


Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Bullboard Posts
Next >>